reference/33120928

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33120928

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	2400
issn	1534-4681 1068-9265
issueIdentifier	8
pageRange	2392-2400
publicationName	Annals of Surgical Oncology
startingPage	2392
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3a43f3f3b25b929cc22db114150a4d0b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e06106c8af9fabca016aa44c6af5799f
bibliographicCitation	Qian J, Xu J, Wang S, Qian F, Yang W, Zhang B, Zhang Y, Nie W, Lou Y, Lu J, Zhang X, Zhang W, Chu T, Zhong H, Fang W, Zhao H, Han B. Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy. Annals of Surgical Oncology. 2019 Apr 22;26(8):2392–400. doi: 10.1245/s10434-019-07366-z.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0731eea4be18b9d8eae72a589dc751b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33c2957b52eb78c3955e613324c274c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eea831d5d36d3a98565f3926f7111b73 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f414fa6845f7d062ddf26dc0d89d635 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd242cd89ed3cd468c471dd425c8bd6f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c49e070cd01ca53f55128ce34e8bc3fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f7f77be8a7786b245939307571a4661 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68ae00b44d58157756128330e72b40cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74a8593fa8ee77177af4f09ca4a537c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66a0eff99d9e77db324961ba30647a70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_968d68b9e6be33292b7e40907203541e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ef7ef4143cf2b66733c67c01d779121 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3330e3c88e8a904fa1b109dc7178a3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_325101bd5fd390549fa483a8847dc3cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7343-9706 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53cd8ce6f27a80af59906b1940075821 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e45870ccb04bb7d330ded8a894817fb3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2eac4bd2e1d470bd9e195a2a48b1b996
date	2019-04-22^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/31011907 https://doi.org/10.1245/s10434-019-07366-z
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8578 https://portal.issn.org/resource/ISSN/1068-9265 https://portal.issn.org/resource/ISSN/1534-4681
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D049451 http://id.nlm.nih.gov/mesh/D000077192Q000188 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D017024Q000401 http://id.nlm.nih.gov/mesh/D009364Q000175 http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000077192Q000473 http://id.nlm.nih.gov/mesh/D047368 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D002681Q000453 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D009361 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D015994 http://id.nlm.nih.gov/mesh/D009364Q000401 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D011013 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012307 http://id.nlm.nih.gov/mesh/D009364Q000453 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10509 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650

Showing number of triples: 1 to 68 of 68.